Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kith Pradhan

Showing results (31-40 of 88) with videos related to

Pageof 9
Sort By:
Cancer|November 27, 2019
Epidemiology and survival trend of adult T-cell leukemia/lymphoma in the United StatesUrvi A Shah, Nishi Shah, Baozhen Qiao, et al.
Genome Research|October 8, 2017
Altered hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathwaysSanchari Bhattacharyya, Kith Pradhan, Nathaniel Campbell, et al.
Cell|October 7, 2017
Brain-wide Maps Reveal Stereotyped Cell-Type-Based Cortical Architecture and Subcortical Sexual DimorphismYongsoo Kim, Guangyu Robert Yang, Kith Pradhan, et al.
Communications Biology|September 2, 2021
Rates of contributory de novo mutation in high and low-risk autism familiesSeungtai Yoon, Adriana Munoz, Boris Yamrom, et al.
Blood Cancer Discovery|July 12, 2022
PU.1-Dependent Enhancer Inhibition Separates Tet2-Deficient Hematopoiesis from Malignant TransformationMaria M Aivalioti, Boris A Bartholdy, Kith Pradhan, et al.
Blood Advances|January 4, 2018
Hispanic ethnicity is associated with younger age at presentation but worse survival in acute myeloid leukemiaKarine Darbinyan, Aditi Shastri, Anjali Budhathoki, et al.
Annals of Hematology|July 24, 2024
Socio-demographic determinants of myelofibrosis outcomes in an underserved center and the SEER national databaseJohn Yan, M Bakri Hammami, John X Wei, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 21, 2023
A Metabolically Optimized, Noncytotoxic Low-Dose Weekly Decitabine/Venetoclax in MDS and AMLDavid Levitz, Yogen Saunthararajah, Kateryna Fedorov, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 14, 2019
PAK Kinase Inhibition Has Therapeutic Activity in Novel Preclinical Models of Adult T-Cell Leukemia/LymphomaElaine Y Chung, Yun Mai, Urvi A Shah, et al.
Journal of Hematology & Oncology|May 23, 2022
Innate immune mediator, Interleukin-1 receptor accessory protein (IL1RAP), is expressed and pro-tumorigenic in pancreatic cancerYang Zhang, Xiaoyi Chen, Huamin Wang, et al.
Pageof 9

Showing results (31-40 of 88) with videos related to

Sort By:
Pageof 9
Cancer|November 27, 2019
Epidemiology and survival trend of adult T-cell leukemia/lymphoma in the United StatesUrvi A Shah, Nishi Shah, Baozhen Qiao, et al.
Genome Research|October 8, 2017
Altered hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathwaysSanchari Bhattacharyya, Kith Pradhan, Nathaniel Campbell, et al.
Cell|October 7, 2017
Brain-wide Maps Reveal Stereotyped Cell-Type-Based Cortical Architecture and Subcortical Sexual DimorphismYongsoo Kim, Guangyu Robert Yang, Kith Pradhan, et al.
Communications Biology|September 2, 2021
Rates of contributory de novo mutation in high and low-risk autism familiesSeungtai Yoon, Adriana Munoz, Boris Yamrom, et al.
Blood Cancer Discovery|July 12, 2022
PU.1-Dependent Enhancer Inhibition Separates Tet2-Deficient Hematopoiesis from Malignant TransformationMaria M Aivalioti, Boris A Bartholdy, Kith Pradhan, et al.
Blood Advances|January 4, 2018
Hispanic ethnicity is associated with younger age at presentation but worse survival in acute myeloid leukemiaKarine Darbinyan, Aditi Shastri, Anjali Budhathoki, et al.
Annals of Hematology|July 24, 2024
Socio-demographic determinants of myelofibrosis outcomes in an underserved center and the SEER national databaseJohn Yan, M Bakri Hammami, John X Wei, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 21, 2023
A Metabolically Optimized, Noncytotoxic Low-Dose Weekly Decitabine/Venetoclax in MDS and AMLDavid Levitz, Yogen Saunthararajah, Kateryna Fedorov, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 14, 2019
PAK Kinase Inhibition Has Therapeutic Activity in Novel Preclinical Models of Adult T-Cell Leukemia/LymphomaElaine Y Chung, Yun Mai, Urvi A Shah, et al.
Journal of Hematology & Oncology|May 23, 2022
Innate immune mediator, Interleukin-1 receptor accessory protein (IL1RAP), is expressed and pro-tumorigenic in pancreatic cancerYang Zhang, Xiaoyi Chen, Huamin Wang, et al.
Pageof 9